Investor FAQs

Show All

What does Treace do?

We are a commercial-stage orthopaedic medical device company with the goal of advancing the standard of care for the surgical management of bunion deformities. Bunions are complex 3-dimensional deformities that originate from an unstable joint in the middle of the foot. We have pioneered and patented the Lapiplasty® 3D Bunion Correction™ system - a combination of instruments, implants, and surgical methods designed to correct all 3 planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and getting patients back to their active lives quickly.

Where is Treace’s corporate headquarters?

Our principal executive offices are located at 203 Fort Wade Road, Suite 150, Ponte Vedra, FL 32081, and our telephone number is (904) 373-5940.

Where and when was Treace incorporated?

We were initially formed as a medical device consulting business in July 2013 and began focusing on the foot and ankle market in January 2014. We converted from a Florida limited liability company to a Delaware corporation on July 1, 2014, changing our name to Treace Medical Concepts, Inc.

On what stock exchange are Treace shares traded, and what is the ticker symbol?

Our ticker is TMCI and it is traded on the NASDAQ exchange.

Does Treace have a direct stock purchase plan?

We do not currently have a direct stock purchase plan.

Where can I find all of Treace’s SEC filings? Where can I download and view quarterly and annual reports?

Quarterly and annual reports, as well as other SEC filings, can be accessed in the SEC Filings section of our Investor Relations website or directly from the SEC at www.sec.gov.

When does Treace fiscal year end?

Our fiscal year end is December 31.

Does Treace pay dividends?

We do not intend to pay cash dividends on our common stock, as we intend to retain all available funds and any future earnings to support operations and finance the growth and development of our business.

Who are the Company's independent registered public accountants?

Our independent registered public accountants are Grant Thornton LLP.

Who is the Company’s transfer agent?

We use American Stock Transfer & Trust Company, LLC. Their address is 6201 15th Avenue, Brooklyn, New York 11219. Their telephone number is (800) 937-5449 or (718) 921-8124 for callers outside of the U.S. and Canada.

Who are the members of Treace Board of Directors?

You can view our Board of Directors by visiting the Board of Directors section of our website.

Who are the members of the Treace management team?

You can view our management team by visiting the Management section of our website.

When is your next earnings release?

We will issue a national press release that includes the date of our quarterly earnings call. When the release is issued, it will be posted on the Events section of our website along with the details for a conference and/or webcast to discuss the results.

How do I contact Investor Relations with a question or request?

You can contact Treace’s Investor Relations via email at: IR@treace.net.

Who to contact with questions about Treace shares or dividends?

If your shares are held in street name (by your broker), you must notify the securities firm holding your stock. If you hold stock certificates in your name, you may reach our transfer agent at the address or phone numbers below or by visiting: www.astfinancial.com.

American Stock Transfer & Trust Company, LLC
6201 15th Avenue
Brooklyn, New York 11219
(800) 937-5449 for U.S. and Canada callers
(718) 921-8124 for International callers

Can I replace a lost certificate?

If you hold stock certificates in your name, please contact our transfer agent regarding the replacement of lost certificates at the address or phone numbers below or by visiting www.astfinancial.com.

American Stock Transfer & Trust Company, LLC
6201 15th Avenue
Brooklyn, New York 11219
(800) 937-5449 for U.S. and Canada callers
(718) 921-8124 for International callers